Excision Repair Cross-Complementing Group-1 (ERCC1) Induction Kinetics and Polymorphism Are Markers of Inferior Outcome in Patients With Colorectal Cancer Treated With Oxaliplatin
Oncotarget - United States
doi 10.18632/oncotarget.27140
Full Text
Open PDFAbstract
Available in full text
Categories
Date
September 17, 2019
Authors
Publisher
Impact Journals, LLC